The Business Times

Bayer to pay US$40m to end whistle-blower claims

Published Sat, Sep 3, 2022 · 08:36 AM

BAYER agreed to pay US$40 million to resolve US lawsuits linked to allegations that company officials bribed hospitals and physicians to use its drugs, the Justice Department (DOJ) said.

The settlement stems from 2 “whistle-blower” suits filed by former Bayer marketing employee Laurie Simpson almost 2 decades ago and subsequent litigation by the US government, the DOJ said on Friday (Sep 2) in a statement. Simpson will receive about US$11 million from the settlement, the department said. 

Bayer, one of the world’s largest pharmaceutical companies, didn’t immediately respond to a request for comment. Under the settlement, Bayer didn’t admit liability, DOJ said.

The company was accused of violating the US False Claims Act in connection with the drugs Trasylol, Avelox and Baycol, the department said. The lawsuits alleged unlawful actions, including paying kickbacks, marketing drugs off-label and downplaying their safety risks.

Simpson alleged Germany-based Bayer and some US units caused the submission of false claims to Medicare and Medicaid programmes and violated the laws of 20 states and Washington, DC. BLOOMBERG

GET BT IN YOUR INBOX DAILY

Start and end each day with the latest news stories and analyses delivered straight to your inbox.

VIEW ALL

KEYWORDS IN THIS ARTICLE

READ MORE

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Consumer & Healthcare

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here